The treatments were well-tolerated, and the mice bearing BRG1-KO (KO3)-derived tumors and treated with LBH + AZA showed the slowest tumor growth and longer survival compared to the other groups (Figure 6C). The gene discussed is SMARCA4; the disease is neoplasm.